Semma Therapeutics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $937M

Semma Therapeutics General Information

Description

Operator of a cell therapy and biotechnology company intended to develop transformative therapy with the curative use of stem cells in regenerative medicines. The company specializes in developing cell-based therapies for type 1 diabetes patients which traditionally require the use of an invasive insulin pump or multiple daily insulin injections combining proprietary cells with a state-of-the-art device, thereby eliminating the use of insulin injections and providing a functional cure for patients with diabetes.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 100 Technology Square
  • Floor 3
  • Cambridge, MA 02139
  • United States
+1 (857) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Semma Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 10-Oct-2019 $937M 00000 00000 Completed Generating Revenue
4. Early Stage VC (Series B) 30-Nov-2017 00000 00000 Completed Startup
3. Grant 12-Sep-2016 000 0000 Completed Startup
2. Early Stage VC (Series A) 24-Mar-2015 $44M $44M 000.00 Completed Startup
1. Spin-Off 01-Dec-2014 Completed Startup
To view Semma Therapeutics’s complete valuation and funding history, request access »

Semma Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view Semma Therapeutics’s complete cap table history, request access »

Semma Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a cell therapy and biotechnology company intended to develop transformative therapy with the curative use of
Biotechnology
Cambridge, MA
00000
00000 0000-00-00
000000&0 00000

000000

lit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim
0000000000000
South San Francisco, CA
00 As of 0000
00000
00000 0000-00-00
00000000000 00000

000000

d minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea
0000000000000
Madison, WI
00.000
0000000000 0 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Semma Therapeutics Competitors (66)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Neurona Therapeutics Venture Capital-Backed South San Francisco, CA 00 00000 00000000000 00000
Regenerative Medical Solutions Venture Capital-Backed Madison, WI 00.000 0000000000 0 00.000
Sernova Corporation London, Canada 00 000.00 000000000 000.00
Seraxis Venture Capital-Backed Germantown, MD 00 000.00 0000000000 0 000.00
Century Therapeutics Formerly VC-backed Philadelphia, PA 000 00000 000000000 00000
You’re viewing 5 of 66 competitors. Get the full list »

Semma Therapeutics Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
6 Dimensions Capital Venture Capital Minority 000 0000 000000 0
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
California Institute for Regenerative Medicine Government 000 0000 000000 0
Cowen Healthcare Investments Venture Capital Minority 000 0000 000000 0
Eight Roads Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Semma Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CytoSolv 16-Nov-2015 0000000000 Biotechnology 0000000 0
To view Semma Therapeutics’s complete acquisitions history, request access »

Semma Therapeutics FAQs

  • When was Semma Therapeutics founded?

    Semma Therapeutics was founded in 2014.

  • Who is the founder of Semma Therapeutics?

    Felicia Pagliuca Ph.D, Robert Millman JD, and Douglas Melton Ph.D are the founders of Semma Therapeutics.

  • Where is Semma Therapeutics headquartered?

    Semma Therapeutics is headquartered in Cambridge, MA.

  • What industry is Semma Therapeutics in?

    Semma Therapeutics’s primary industry is Biotechnology.

  • Is Semma Therapeutics a private or public company?

    Semma Therapeutics is a Private company.

  • What is the current valuation of Semma Therapeutics?

    The current valuation of Semma Therapeutics is 00000.

  • What is Semma Therapeutics’s current revenue?

    The current revenue for Semma Therapeutics is 000000.

  • How much funding has Semma Therapeutics raised over time?

    Semma Therapeutics has raised $158M.

  • Who are Semma Therapeutics’s investors?

    6 Dimensions Capital, ARCH Venture Partners, California Institute for Regenerative Medicine, Cowen Healthcare Investments, and Eight Roads are 5 of 14 investors who have invested in Semma Therapeutics.

  • Who are Semma Therapeutics’s competitors?

    Neurona Therapeutics, Regenerative Medical Solutions, Sernova, Seraxis, and Century Therapeutics are some of the 66 competitors of Semma Therapeutics.

  • When was Semma Therapeutics acquired?

    Semma Therapeutics was acquired on 10-Oct-2019.

  • Who acquired Semma Therapeutics?

    Semma Therapeutics was acquired by Vertex Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »